Stockholders' Equity (Tables)

6 Months Ended

Dec. 31, 2017

Stockholders' Equity

Schedule of stock-based compensation expense in the condensed consolidated statements of operations

We recorded stock-based compensation expense in the condensed consolidated statements of operations as follows (in thousands):

	Three Months Ended December 31,						Six Months Ended December 31,
	2016			2017			2016			2017
Cost of goods sold	$	404		$	247		$	699		$	487
Selling, general and administrative	5,222			5,849			10,282			10,960
Research and development	121			157			176			293
Restructuring	2,482			—			2,902			—
Stock-based compensation expense before taxes	$	8,229		$	6,253		$	14,059		$	11,740
Less: related income tax benefit	(3,206		)	(1,935		)	(5,450		)	(3,627		)
Stock-based compensation expense, net of estimated taxes	$	5,023		$	4,318		$	8,609		$	8,113

Summary of stock option activity

	Number of Options		Weighted Average Exercise Price		Weighted- Average Remaining Contractual Term	Aggregate Intrinsic Value (in thousands)
Outstanding at June 30, 2017	780,671		$	30.00
Granted	25,379		$	85.83
Exercised	(81,755	)	$	22.84
Expired or forfeited	(1,904	)	$	63.33
Outstanding at December 31, 2017	722,391		$	32.68	3.3 years	$	23,985
Exercisable at December 31, 2017	674,129		$	29.30	2.9 years	$	23,983

Summary of RSU award activity

	Shares		Weighted- Average Fair Value
Nonvested at June 30, 2017	611,687		$	65.85
Granted	348,187		74.14
Vested	(400,338	)	65.26
Forfeited	(10,596	)	68.20
Nonvested at December 31, 2017	548,940		$	71.50